pmid	doi	title	Hugo_Symbol
36009586	10.3390/biomedicines10082038	Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma.	NFKB1
35021606	10.3324/haematol.2021.280003	Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.	NFKB1
34401669	10.1016/j.isci.2021.102888	Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway.	NFKB1
34364837	10.1016/j.cbi.2021.109619	Anticancer effects of oleanolic acid on human melanoma cells.	NFKB1
33684151	10.1371/journal.pone.0248259	SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.	NFKB1
33202260	10.1016/j.ajhg.2020.10.015	Multiplexed Functional Assessment of Genetic Variants in CARD11.	NFKB1
32912211	10.1186/s12977-020-00538-w	A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells.	NFKB1
32712875	10.1007/s11064-020-03096-x	miR-29c-3p Increases Cell Viability and Suppresses Apoptosis by Regulating the TNFAIP1/NF-κB Signaling Pathway via TNFAIP1 in Aβ-Treated Neuroblastoma Cells.	NFKB1
31803180	10.3389/fimmu.2019.02618	Late-Onset Antibody Deficiency Due to Monoallelic Alterations in <i>NFKB1</i>.	NFKB1
31497245	10.18632/oncotarget.27098	Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma.	NFKB1
31344550	10.1016/j.virol.2019.07.011	Association of polymorphisms in NFκB1 promoter and NFκBIA gene with the development of antibodies against HHV-8 in HIV-infected individuals.	NFKB1
30885361	10.1016/bs.acr.2019.01.004	HVEM network signaling in cancer.	NFKB1
30711250	10.1016/j.bbrc.2019.01.089	NF-κB-dependent RANKL expression in a mouse model of immature T-cell leukemia.	NFKB1
30127896	10.3892/ol.2018.9010	Burkitt lymphoma-associated network construction and important network motif analysis.	NFKB1
29593668	10.3389/fmicb.2018.00380	Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins.	NFKB1
29449436	10.3324/haematol.2017.182048	Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients.	NFKB1
29333957	10.1177/1533034617745761	MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway.	NFKB1
28689659	10.1016/j.molcel.2017.06.011	Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.	NFKB1
28684863	10.1038/emm.2017.89	Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.	NFKB1
28672935	10.3892/etm.2017.4464	Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.	NFKB1
28369050	10.1038/ni.3716	Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.	NFKB1
28368397	10.1038/onc.2017.90	Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.	NFKB1
28281555	10.1038/modpathol.2017.5	NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.	NFKB1
27489104	10.1074/jbc.M116.719302	The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.	NFKB1
27338827	10.1007/s10875-016-0306-1	NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.	NFKB1
26767426	10.1016/j.jid.2015.12.027	MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.	NFKB1
26573110	10.3892/ijo.2015.3238	Involvement of cyclic-nucleotide response element-binding family members in the radiation response of Ramos B lymphoma cells.	NFKB1
26526716	10.1053/j.gastro.2015.10.017	BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.	NFKB1
26487345	10.1038/srep15215	Transcription factor and miRNA co-regulatory network reveals shared and specific regulators in the development of B cell and T cell.	NFKB1
26477771	10.3760/cma.j.issn.0253-2727.2015.10.016	[Clinical significance of NF-κB/p65 expression in patients with diffuse large B-cell lymphoma].	NFKB1
26391888	10.1038/srep14315	Genome-wide homozygosity signature and risk of Hodgkin lymphoma.	NFKB1
26060405	10.2147/OTT.S82936	Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis.	NFKB1
26043790	10.1080/15548627.2015.1052205	Cocaine-mediated microglial activation involves the ER stress-autophagy axis.	NFKB1
25951043	10.1080/15548627.2015.1017192	The role of STAT3 in autophagy.	NFKB1
25922067	10.1074/jbc.M115.643700	Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.	NFKB1
27308399	10.4161/23723548.2014.968073	Nfkb1 suppresses DNA alkylation-induced tumor formation.	NFKB1
25541152	10.1038/leu.2014.351	MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.	NFKB1
25394713	10.1038/leu.2014.324	GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.	NFKB1
24459141	10.1074/jbc.M114.551986	Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.	NFKB1
24292677	10.1038/onc.2013.503	YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.	NFKB1
23868181	10.1002/path.4239	Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.	NFKB1
23821202	10.1167/iovs.13-12272	MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.	NFKB1
23441730	10.1042/BJ20121651	The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system.	NFKB1
23360303	10.1111/bjh.12206	The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.	NFKB1
22553204	10.1074/jbc.M112.340992	Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.	NFKB1
21902578	10.3109/10428194.2011.621566	Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.	NFKB1
21249144	10.1371/journal.pone.0016171	Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.	NFKB1
21189087	10.1902/jop.2010.100312	Real-time quantitative polymerase chain reaction analysis of patients with refractory chronic periodontitis.	NFKB1
20410275	10.1128/JVI.00344-10	Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.	NFKB1
19223558	10.1158/1055-9965.EPI-08-1130	Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.	NFKB1
18990758	10.1158/1055-9965.EPI-08-0536	Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.	NFKB1
18596915	10.1371/journal.pone.0002555	RelB-dependent stromal cells promote T-cell leukemogenesis.	NFKB1
18287044	10.1073/pnas.0712313105	NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation.	NFKB1
17641042	10.4049/jimmunol.179.3.1760	OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites.	NFKB1
17573907	10.1111/j.1462-5822.2007.00950.x	Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein.	NFKB1
17356384	10.1097/01.jnen.0000248553.45456.96	Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.	NFKB1
16778171	10.1158/0008-5472.CAN-06-0194	NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.	NFKB1
16751281	10.1073/pnas.0507809103	The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.	NFKB1
16288225	10.1038/sj.onc.1209178	Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.	NFKB1
16037393	10.1182/blood-2004-12-4965	Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals.	NFKB1
15940251	10.1038/sj.onc.1208779	Nfkb 1 is dispensable for Myc-induced lymphomagenesis.	NFKB1
15546001	10.1172/JCI21696	Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy.	NFKB1
15231650	10.1158/0008-5472.CAN-03-3885	High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.	NFKB1
15153339	10.1593/neo.3388	Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.	NFKB1
12058256	10.1038/sj.gene.6363846	Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.	NFKB1
10670837	10.1097/00024382-200013020-00001	NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome.	NFKB1
10390192	10.1016/s0301-472x(99)00053-3	NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications.	NFKB1
9480976	10.1084/jem.187.5.663	B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.	NFKB1
9218802	10.1093/emboj/16.12.3609	Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.	NFKB1
9021684	10.3109/10428199609054800	The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.	NFKB1
8378093		Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.	NFKB1
7692229	10.1128/mcb.13.10.6283-6289.1993	Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells.	NFKB1
1612589	10.1016/0888-7543(92)90244-m	Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.	NFKB1
31803180	10.3389/fimmu.2019.02618	Late-Onset Antibody Deficiency Due to Monoallelic Alterations in <i>NFKB1</i>.	NFKB1
30787019	10.1182/bloodadvances.2018029322	Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation-induced senescence.	NFKB1
30711173	10.1016/j.joen.2018.10.006	Inhibition of Nuclear Factor Kappa B Prevents the Development of Experimental Periapical Lesions.	NFKB1
30696620	10.1182/blood-2018-08-871293	Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.	NFKB1
28346502	10.1371/journal.pone.0174136	EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.	NFKB1
27546290	10.1016/j.semcancer.2016.08.001	Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma.	NFKB1
27503810	10.1016/j.semcancer.2016.08.002	NF-κB deregulation in splenic marginal zone lymphoma.	NFKB1
27452667	10.1016/j.semcancer.2016.07.003	MALT lymphoma: A paradigm of NF-κB dysregulation.	NFKB1
27402288	10.1016/j.semcancer.2016.07.001	Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.	NFKB1
27338827	10.1007/s10875-016-0306-1	NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.	NFKB1
27262792	10.1016/j.semcancer.2016.05.002	Mechanisms of NF-κB deregulation in lymphoid malignancies.	NFKB1
27221964	10.1016/j.semcancer.2016.05.001	NF-κB deregulation in Hodgkin lymphoma.	NFKB1
26612043	10.1007/s11427-015-4977-2	Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.	NFKB1
26606782		[PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS].	NFKB1
26275874	10.1007/82_2015_479	Roles of the NF-κB Pathway in B-Lymphocyte Biology.	NFKB1
26049760	10.1097/MOH.0000000000000160	Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis.	NFKB1
25960206	10.1002/gcc.22253	NFkB is activated by multiple mechanisms in hairy cell leukemia.	NFKB1
25636172	10.1016/j.humpath.2014.06.032	Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma.	NFKB1
24867094	10.1007/s13277-014-1998-6	Crebanine, an aporphine alkaloid, sensitizes TNF-α-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-κB-regulated gene products.	NFKB1
24704296	10.1016/j.canlet.2014.03.030	The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma.	NFKB1
24419302	10.1007/s00018-013-1545-4	NF-κB pathways in hematological malignancies.	NFKB1
24296945	10.1038/leu.2013.365	Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.	NFKB1
24200242	10.1089/scd.2013.0270	Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature.	NFKB1
23886693	10.1016/j.imbio.2013.06.013	Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.	NFKB1
23328932	10.1007/s00428-013-1372-x	Nuclear factor-κB activation in primary lymphoma of bone.	NFKB1
22538516	10.1038/modpathol.2012.52	EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.	NFKB1
21743832	10.3390/v3060714	Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.	NFKB1
21574100		Activation of NF-ĸB in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukaemia: relation to other prognostic factors.	NFKB1
20106524	10.1016/j.leukres.2009.12.014	NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.	NFKB1
19469019	10.1111/j.1349-7006.2009.01083.x	Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation.	NFKB1
19412164	10.1038/nature07968	Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.	NFKB1
19279104	10.1128/JVI.00097-09	The LMP1 promoter can be transactivated directly by NF-kappaB.	NFKB1
19021048	10.1080/10428190802444176	Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.	NFKB1
18316375	10.1074/jbc.M707988200	Sequestration of NF-kappaB signaling complexes in lipid rafts contributes to repression of NF-kappaB in T lymphocytes under hyperthermia stress.	NFKB1
18006844	10.1158/0008-5472.CAN-07-0519	Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.	NFKB1
17555878	10.1016/j.bbagen.2007.04.011	Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-kappaB.	NFKB1
16439988	10.1038/sj.cdd.4401856	Deciphering the pathway from the TCR to NF-kappaB.	NFKB1
16270046	10.1038/sj.leu.2403960	Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.	NFKB1
16219794	10.1182/blood-2005-06-2536	Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.	NFKB1
15190178	10.1073/pnas.0308016101	Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).	NFKB1
12058256	10.1038/sj.gene.6363846	Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.	NFKB1
10931834	10.1074/jbc.M004148200	NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.	NFKB1
33707466	10.1038/s41598-021-84912-4	CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma.	NFKB1
33025009	10.1182/blood.2020004918	MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis.	NFKB1
32912211	10.1186/s12977-020-00538-w	A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells.	NFKB1
31574234	10.1096/fj.201900101RR	Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells <i>via</i> up-regulation of MEST through NF-κB1.	NFKB1
31344550	10.1016/j.virol.2019.07.011	Association of polymorphisms in NFκB1 promoter and NFκBIA gene with the development of antibodies against HHV-8 in HIV-infected individuals.	NFKB1
29976660	10.1128/JVI.00580-18	Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.	NFKB1
29698475	10.1371/journal.ppat.1006968	CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.	NFKB1
29020881	10.1080/10245332.2017.1385194	Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway.	NFKB1
28368397	10.1038/onc.2017.90	Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.	NFKB1
28281555	10.1038/modpathol.2017.5	NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.	NFKB1
28232371	10.3324/haematol.2016.156281	c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.	NFKB1
28028966	10.17219/acem/63752	Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia.	NFKB1
27840321	10.1016/j.freeradbiomed.2016.11.010	Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2.	NFKB1
25996250	10.1111/febs.13325	MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.	NFKB1
25987724	10.1084/jem.20142009	Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.	NFKB1
25837675	10.1158/1535-7163.MCT-14-1053	MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NFκB Activation in Breast Cancer.	NFKB1
24292677	10.1038/onc.2013.503	YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.	NFKB1
23869088	10.1182/blood-2013-06-508028	IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL.	NFKB1
23821202	10.1167/iovs.13-12272	MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.	NFKB1
23752607	10.5604/17322693.1052449	Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.	NFKB1
23028875	10.1371/journal.pone.0045244	Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.	NFKB1
22384168	10.1371/journal.pone.0032168	Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.	NFKB1
21994759	10.3390/v3060886	Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.	NFKB1
21979375	10.1101/gad.17276711	Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.	NFKB1
21979374	10.1101/gad.17620611	Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations.	NFKB1
21110852	10.1186/1756-9966-29-154	Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.	NFKB1
20813154	10.1016/j.exphem.2010.08.007	NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma.	NFKB1
20439115	10.1016/j.molimm.2010.04.005	Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.	NFKB1
20414006	10.1159/000313697	NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.	NFKB1
20391111	10.1080/15287390903578521	Granuloma formation induced by low-dose chronic silica inhalation is associated with an anti-apoptotic response in Lewis rats.	NFKB1
19954665		[The action mechanisms of unclassical NF-kappaB activity and TRAF3 expression in Hodgkin's lymphoma cells].	NFKB1
19885551	10.3892/ijo_00000446	Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.	NFKB1
19258598	10.1182/blood-2008-08-174110	The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.	NFKB1
18983609	10.1111/j.1365-2559.2008.03139.x	Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.	NFKB1
18928599		[Expression of survivin and NF-kappaB in peripheral T-cell lymphoma and its significance].	NFKB1
18796561	10.1096/fj.07-104109	Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex.	NFKB1
18668140	10.1038/jid.2008.205	NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.	NFKB1
18661398	10.1080/10428190802216723	CD40L-mediated inhibition of NF-kappaB in CA46 Burkitt lymphoma cells promotes apoptosis.	NFKB1
18344086		[Protein expression and clinical significance of cyclooxygenase 2 and nuclear factor kappa B in gastric mucosa-associated lymphoid tissue lymphoma].	NFKB1
17963943	10.1016/j.virusres.2007.09.003	The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.	NFKB1
16979925	10.1016/j.oraloncology.2006.04.011	Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy.	NFKB1
16778171	10.1158/0008-5472.CAN-06-0194	NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.	NFKB1
16751281	10.1073/pnas.0507809103	The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.	NFKB1
16299251	10.1158/1078-0432.CCR-05-0224	Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.	NFKB1
16123212	10.1182/blood-2004-09-3620	Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.	NFKB1
15979856	10.1016/j.bbadis.2005.05.003	Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.	NFKB1
15940251	10.1038/sj.onc.1208779	Nfkb 1 is dispensable for Myc-induced lymphomagenesis.	NFKB1
15876358	10.1186/1742-4690-2-29	Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.	NFKB1
15870177	10.1182/blood-2004-12-4901	NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.	NFKB1
15147743	10.1016/j.biocel.2004.02.004	Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells.	NFKB1
15068390	10.1007/BF03260037	Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expression.	NFKB1
12032828	10.1038/sj.onc.1205483	NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.	NFKB1
9223487	10.1128/JVI.71.8.5972-5981.1997	VBP and RelA regulate avian leukosis virus long terminal repeat-enhanced transcription in B cells.	NFKB1
9218802	10.1093/emboj/16.12.3609	Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.	NFKB1
1612589	10.1016/0888-7543(92)90244-m	Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.	NFKB1
33684151	10.1371/journal.pone.0248259	SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.	NFKB1
32452133	10.1111/jcmm.15383	MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.	NFKB1
31957805	10.1093/carcin/bgaa005	Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.	NFKB1
30887112	10.1007/s00109-019-01777-x	Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.	NFKB1
30116272	10.1186/s11658-018-0102-4	The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells.	NFKB1
29333957	10.1177/1533034617745761	MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway.	NFKB1
28152513	10.18632/oncotarget.14934	Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1.	NFKB1
27488529	10.1158/0008-5472.CAN-16-0595	TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy.	NFKB1
26792751	10.1128/JVI.03000-15	The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.	NFKB1
26776161	10.1038/onc.2015.493	Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.	NFKB1
26648441	10.3892/mmr.2015.4606	Effects of miR‑590 on oxLDL‑induced endothelial cell apoptosis: Roles of p53 and NF‑κB.	NFKB1
25912249	10.4274/tjh.2014.0190	Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.	NFKB1
25572145	10.1042/BSR20140160	Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.	NFKB1
25394713	10.1038/leu.2014.324	GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.	NFKB1
24971370	10.1155/2014/492872	Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.	NFKB1
24393203	10.1186/1476-4598-13-5	NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia.	NFKB1
24027435	10.1593/neo.131140	Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells.	NFKB1
23603894	10.1254/jphs.12149fp	Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.	NFKB1
22768179	10.1371/journal.pone.0039945	Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.	NFKB1
22362744	10.1093/nar/gks175	MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia.	NFKB1
21902578	10.3109/10428194.2011.621566	Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.	NFKB1
21531730	10.1074/jbc.M111.224048	A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.	NFKB1
21406399	10.1158/0008-5472.CAN-10-3626	CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.	NFKB1
20226764	10.1016/j.bbrc.2010.03.054	Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.	NFKB1
19709433	10.1186/1476-4598-8-67	STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.	NFKB1
19540595	10.1016/j.molimm.2009.05.178	TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.	NFKB1
19129458	10.1128/JVI.01512-08	A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation.	NFKB1
18640717	10.1016/j.leukres.2008.06.010	PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines.	NFKB1
18398749	10.1080/10428190801910912	Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways.	NFKB1
18006812	10.1158/0008-5472.CAN-07-1708	Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.	NFKB1
17502353	10.1128/MCB.01645-06	Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation.	NFKB1
16497967	10.1182/blood-2005-10-4042	Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.	NFKB1
15982633	10.1016/j.bbrc.2005.06.058	API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.	NFKB1
14747545	10.1128/jvi.78.4.1800-1816.2004	Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.	NFKB1
12972607	10.1128/MCB.23.19.6887-6900.2003	Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.	NFKB1
9572494	10.1038/sj.onc.1201735	Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.	NFKB1
8196632	10.1128/mcb.14.6.3915-3926.1994	BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.	NFKB1
8428580	10.1002/j.1460-2075.1993.tb05647.x	The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.	NFKB1
27440900	10.1128/JVI.00797-16	HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.	NFKB1
25922067	10.1074/jbc.M115.643700	Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.	NFKB1
24548923	10.1016/j.molimm.2014.01.011	Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.	NFKB1
24059932	10.1186/1471-2199-14-24	Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter.	NFKB1
22267549	10.1158/1535-7163.MCT-11-0635	Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.	NFKB1
21987722	10.1158/0008-5472.CAN-11-1715	IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.	NFKB1
21873235	10.1073/pnas.1105020108	Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.	NFKB1
21273489	10.1126/science.1198946	Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.	NFKB1
20507572	10.1186/1471-2172-11-26	Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.	NFKB1
19243308	10.1042/BJ20082140	Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.	NFKB1
18025803	10.1159/000111116	Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.	NFKB1
17577783	10.1080/10428190701340616	Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia.	NFKB1
10469655	10.1093/emboj/18.17.4766	NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.	NFKB1
10023675	10.1038/sj.onc.1202374	Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.	NFKB1
22394598	10.1182/blood-2011-10-386011	ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.	NFKB1
21674474	10.1002/eji.201041052	Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-κB activation in Th cells.	NFKB1
21417823	10.3109/10428194.2011.565437	The secret second life of an innocent chaperone: the story of CD74 and B cell/chronic lymphocytic leukemia cell survival.	NFKB1
15514680	10.1038/sj.embor.7400280	Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds.	NFKB1
14678988		Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.	NFKB1
35089437	10.1007/s00018-022-04139-y	A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection.	NFKB1
12145210	10.1093/emboj/cdf389	Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.	NFKB1
9584180	10.1128/MCB.18.6.3395	Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription.	NFKB1
9250404	10.1379/1466-1268(1997)002&lt;0132:msphiw&gt;2.3.co;2	Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells.	NFKB1
22435562	10.1111/j.1600-065X.2012.01094.x	Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis.	NFKB1
20800578	10.1016/j.bbrc.2010.08.084	Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer.	NFKB1
19234489	10.1038/onc.2009.17	TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.	NFKB1
16891304	10.1074/jbc.M605116200	The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.	NFKB1
16108830	10.1111/j.1349-7006.2005.00078.x	Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.	NFKB1
15315758	10.1016/j.cell.2004.08.007	One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers.	NFKB1
8113688	10.1084/jem.179.3.961	The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.	NFKB1
19223558	10.1158/1055-9965.EPI-08-1130	Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.	NFKB1
18252714	10.1074/jbc.M708833200	Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells.	NFKB1
17626072	10.1128/JVI.02241-06	Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.	NFKB1
16306601	10.1128/JVI.79.24.15302-15313.2005	Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.	NFKB1
15802604	10.1126/science.1107107	PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.	NFKB1
15184390	10.1074/jbc.M402244200	Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator.	NFKB1
20558726	10.1074/jbc.M110.112128	BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.	NFKB1
26668357	10.1073/pnas.1507459112	Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.	NFKB1
11830587	10.1074/jbc.M110480200	The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.	NFKB1
26112410	10.1074/jbc.M114.630061	The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.	NFKB1
19897484	10.1074/jbc.M109.050815	B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.	NFKB1
15469820	10.1016/j.molcel.2004.09.004	GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.	NFKB1
20547759	10.1128/MCB.01600-09	The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.	NFKB1
18625728	10.1128/MCB.00418-08	The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.	NFKB1
18990758	10.1158/1055-9965.EPI-08-0536	Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.	NFKB1
21061265	10.1002/mc.20688	Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.	NFKB1
20716621	10.1158/1055-9965.EPI-10-0389	Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia.	NFKB1
20438785	10.1016/j.humimm.2010.04.004	Polymorphisms in innate immunity genes and risk of childhood leukemia.	NFKB1
19773279	10.1136/oem.2008.044024	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	NFKB1
19573080	10.1111/j.1365-2141.2009.07790.x	Common genetic variants in candidate genes and risk of familial lymphoid malignancies.	NFKB1
18636124	10.1371/journal.pone.0002816	Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.	NFKB1
10362352	10.1038/sj.onc.1202717	The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.	NFKB1
